Table of Contents
Volume 3 | Issue 3
Publication Date: February 2002- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
168 |
Extensive-Stage Small-Cell Lung Cancer: Is the Progress Real? Chandra P. Belani |
|
Meeting Highlights | ||
171-176 |
Highlights From: The 2001 European Cancer Conference, Lisbon, Portugal Kavita Maung, Maxine Fisher |
|
Research in Brief | ||
177-179 |
Docetaxel Plus Cisplatin Combinations in Advanced Non–Small-Cell Lung Cancer Maxine D. Fisher, Thomas J. Lynch, Jr |
|
Comprehensive Reviews | ||
180-190 |
Clinical Benefits of Epoetin Alfa Therapy in Patients with Lung Cancer Jeffrey Crawford, George D. Demetri, Janice L. Gabrilove, Michael V. Blasi, Brenda J. Sarokhan, John Glaspy |
|
191-199 |
The Treatment of Unresectable, Locally Advanced Non–Small-Cell Lung Cancer: A Radiation Therapy Perspective with an Emphasis on the Trials of the Radiation Therapy Oncology Group Lisa J. Hazard, William T. Sause |
|
Original Contributions | ||
200-204 |
A Retrospective Analysis Comparing Patients 70 Years or Older to Patients Younger than 70 Years with Non–Small-Cell Lung Cancer Treated with Surgery at Indiana University: 1989-1999 Nasser Hanna, Jo Ann Brooks, Joanne Fyffe, Kenneth Kesler |
|
205-210 |
Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430) Alan P. Lyss, James E. Herndon, II, Thomas J. Lynch, Jr., Andrew T. Turrisi, Dorothy M. Watson, Sara J. Grethlein, Mark R. Green |
|
Commentary | ||
211-212 |
Commentary on “Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)” Raymond P. Abratt |
|
Translational Medicine | ||
213-218 |
Role of Small-Molecule Kit Receptor Tyrosine Kinase Inhibitors in the Treatment of Small-Cell Lung Cancer Katherine P. Lloyd, Geoffrey W. Krystal |
|
Brief Communication | ||
219-222 |
A Phase II Study of the Immunotoxin N901-Blocked Ricin in Small-Cell Lung Cancer Panos Fidias, Michael Grossbard, Thomas J. Lynch, Jr |
|